{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=bimatoprost+ophthalmic+solution", "query": { "intervention": "bimatoprost ophthalmic solution" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 53, "total_pages": 6, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=bimatoprost+ophthalmic+solution&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-22T16:35:18.912Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04890106", "title": "Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma, Open-Angle" ], "interventions": [ { "name": "Test - Bimatoprost 0.01% Ophthalmic Solution", "type": "DRUG" }, { "name": "Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mankind Pharma Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 310, "start_date": "2021-10-02", "completion_date": "2022-08-11", "has_results": false, "last_update_posted_date": "2022-12-13", "last_synced_at": "2026-09-22T16:35:18.912Z", "location_count": 9, "location_summary": "Bakersfield, California • Mission Hills, California • Newport Beach, California + 5 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04890106" }, { "nct_id": "NCT05397600", "title": "Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost Ophthalmic", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Laboratoires Thea", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 684, "start_date": "2022-06-22", "completion_date": "2024-03-07", "has_results": false, "last_update_posted_date": "2024-07-18", "last_synced_at": "2026-09-22T16:35:18.912Z", "location_count": 56, "location_summary": "Chandler, Arizona • Glendale, Arizona • Phoenix, Arizona + 47 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Burbank", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05397600" }, { "nct_id": "NCT07218783", "title": "Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cataract", "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost Implant System", "type": "DRUG" }, { "name": "SpyGlass IOL", "type": "DEVICE" }, { "name": "Timolol Maleate Ophthalmic Solution, 0.5%", "type": "DRUG" }, { "name": "Commercial IOL", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "SpyGlass Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 400, "start_date": "2025-10-15", "completion_date": "2031-03-31", "has_results": false, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-09-22T16:35:18.912Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07218783" }, { "nct_id": "NCT05938699", "title": "Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Open Angle Glaucoma" ], "interventions": [ { "name": "NCX 470", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nicox Ophthalmics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2023-12-12", "completion_date": "2025-03-17", "has_results": false, "last_update_posted_date": "2025-09-08", "last_synced_at": "2026-09-22T16:35:18.912Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05938699" }, { "nct_id": "NCT02830776", "title": "Topical Bimatoprost for Chemical Blepharoplasty", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Dermatochalasis" ], "interventions": [ { "name": "bimatoprost 0.03% ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tulane University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2016-11", "completion_date": "2017-06-30", "has_results": true, "last_update_posted_date": "2021-03-05", "last_synced_at": "2026-09-22T16:35:18.912Z", "location_count": 1, "location_summary": "New Orleans, Louisiana", "locations": [ { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02830776" }, { "nct_id": "NCT00809848", "title": "Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Ocular Hypertension", "Glaucoma" ], "interventions": [ { "name": "AGN-210669 ophthalmic solution, 0.075%", "type": "DRUG" }, { "name": "AGN-210669 ophthalmic solution, 0.05%", "type": "DRUG" }, { "name": "AGN-210669 ophthalmic solution, 0.025%", "type": "DRUG" }, { "name": "bimatoprost ophthalmic solution 0.03%", "type": "DRUG" }, { "name": "AGN-210669 vehicle ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 172, "start_date": "2009-02", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2013-10-18", "last_synced_at": "2026-09-22T16:35:18.912Z", "location_count": 1, "location_summary": "Artesia, California", "locations": [ { "city": "Artesia", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00809848" }, { "nct_id": "NCT01291108", "title": "Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "AGN-210669", "type": "DRUG" }, { "name": "bimatoprost", "type": "DRUG" }, { "name": "bimatoprost vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2011-04", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2013-11-06", "last_synced_at": "2026-09-22T16:35:18.912Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01291108" }, { "nct_id": "NCT01001195", "title": "Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "AGN-210669 ophthalmic solution, 0.1%", "type": "DRUG" }, { "name": "AGN-210669 ophthalmic solution, 0.075%", "type": "DRUG" }, { "name": "AGN-210669 ophthalmic solution, 0.05%", "type": "DRUG" }, { "name": "bimatoprost ophthalmic solution 0.03%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 165, "start_date": "2009-11", "completion_date": "2010-04", "has_results": true, "last_update_posted_date": "2013-10-18", "last_synced_at": "2026-09-22T16:35:18.912Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01001195" }, { "nct_id": "NCT00999557", "title": "Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alopecia", "Breast Cancer" ], "interventions": [ { "name": "bimatoprost ophthalmic solution", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jonsson Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2016-01", "completion_date": null, "has_results": false, "last_update_posted_date": "2020-07-31", "last_synced_at": "2026-09-22T16:35:18.912Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00999557" }, { "nct_id": "NCT05401357", "title": "Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "Test - Bimatoprost 0.01% Ophthalmic Solution", "type": "DRUG" }, { "name": "Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amneal Pharmaceuticals, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 168, "start_date": "2022-06-29", "completion_date": "2022-12", "has_results": false, "last_update_posted_date": "2022-08-10", "last_synced_at": "2026-09-22T16:35:18.912Z", "location_count": 9, "location_summary": "Newport Beach, California • Petaluma, California • New Smyrna Beach, Florida + 6 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Petaluma", "state": "California" }, { "city": "New Smyrna Beach", "state": "Florida" }, { "city": "Morrow", "state": "Georgia" }, { "city": "Roswell", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05401357" } ] }